Literature DB >> 21225273

Tau pathology in children and young adults: can you still be unconditionally baptist?

Charles Duyckaerts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21225273     DOI： 10.1007/s00401-010-0794-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  29 in total

1.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

2.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

Review 3.  Immunotherapeutic approaches for Alzheimer's disease.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Neuron       Date:  2015-03-18       Impact factor: 17.173

4.  Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.

Authors:  Anna Kremer; Hervé Maurin; David Demedts; Herman Devijver; Peter Borghgraef; Fred Van Leuven
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

5.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

Review 6.  Alzheimer's disease: experimental models and reality.

Authors:  Eleanor Drummond; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2016-12-26       Impact factor: 17.088

7.  Combination of PKCε Activation and PTP1B Inhibition Effectively Suppresses Aβ-Induced GSK-3β Activation and Tau Phosphorylation.

Authors:  Takeshi Kanno; Ayako Tsuchiya; Akito Tanaka; Tomoyuki Nishizaki
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

Review 8.  Biomarker modeling of Alzheimer's disease.

Authors:  Clifford R Jack; David M Holtzman
Journal:  Neuron       Date:  2013-12-18       Impact factor: 17.173

9.  Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI.

Authors:  Jon B Toledo; Sharon X Xie; John Q Trojanowski; Leslie M Shaw
Journal:  Acta Neuropathol       Date:  2013-06-29       Impact factor: 17.088

Review 10.  Therapeutic strategies for tau mediated neurodegeneration.

Authors:  Yasumasa Yoshiyama; Virginia M Y Lee; John Q Trojanowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-20       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.